| A randomized clinical trial of anti–IL-6 antibody clazakizumab in late antibody-mediated kidney transplant rejection K Doberer, M Duerr, PF Halloran, F Eskandary, K Budde, H Regele, ... Journal of the American Society of Nephrology 32 (3), 708-722, 2021 | 131 | 2021 |
| Contribution of non-HLA incompatibility between donor and recipient to kidney allograft survival: genome-wide analysis in a prospective cohort R Reindl-Schwaighofer, A Heinzel, A Kainz, J van Setten, K Jelencsics, ... The Lancet 393 (10174), 910-917, 2019 | 123 | 2019 |
| Comparison of SARS-CoV-2 antibody response 4 weeks after homologous vs heterologous third vaccine dose in kidney transplant recipients: a randomized clinical trial R Reindl-Schwaighofer, A Heinzel, M Mayrdorfer, R Jabbour, ... JAMA internal medicine 182 (2), 165-171, 2022 | 122 | 2022 |
| NPHP1 (Nephrocystin-1) gene deletions cause adult-onset ESRD R Snoek, J Van Setten, BJ Keating, AK Israni, PA Jacobson, WS Oetting, ... Journal of the American Society of Nephrology 29 (6), 1772-1779, 2018 | 115 | 2018 |
| ACE2 elevation in severe COVID-19 R Reindl-Schwaighofer, S Hödlmoser, F Eskandary, M Poglitsch, ... American journal of respiratory and critical care medicine 203 (9), 1191-1196, 2021 | 106 | 2021 |
| Torque teno virus for risk stratification of graft rejection and infection in kidney transplant recipients—a prospective observational trial K Doberer, M Schiemann, R Strassl, F Haupenthal, F Dermuth, I Görzer, ... American Journal of Transplantation 20 (8), 2081-2090, 2020 | 92 | 2020 |
| CD38 antibody daratumumab for the treatment of chronic active antibody-mediated kidney allograft rejection K Doberer, J Kläger, GA Gualdoni, KA Mayer, F Eskandary, EA Farkash, ... Transplantation 105 (2), 451-457, 2021 | 84 | 2021 |
| Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial F Eskandary, M Dürr, K Budde, K Doberer, R Reindl-Schwaighofer, ... Trials 20, 1-13, 2019 | 63 | 2019 |
| miR-182-5p inhibition ameliorates ischemic acute kidney injury J Wilflingseder, K Jelencsics, H Bergmeister, J Sunzenauer, H Regele, ... The American Journal of Pathology 187 (1), 70-79, 2017 | 62 | 2017 |
| Torque teno virus for risk stratification of acute biopsy-proven alloreactivity in kidney transplant recipients R Strassl, K Doberer, S Rasoul-Rockenschaub, H Herkner, I Görzer, ... The Journal of infectious diseases 219 (12), 1934-1939, 2019 | 61 | 2019 |
| Survival analysis of conservative vs. dialysis treatment of elderly patients with CKD stage 5 R Reindl-Schwaighofer, A Kainz, M Kammer, A Dumfarth, R Oberbauer PloS one 12 (7), e0181345, 2017 | 56 | 2017 |
| Blood disorders after kidney transplantation R Reindl-Schwaighofer, R Oberbauer Transplantation Reviews 28 (2), 63-75, 2014 | 52 | 2014 |
| Recurrence of IgA nephropathy after kidney transplantation in adults A Uffing, MJ Pérez-Saéz, T Jouve, M Bugnazet, P Malvezzi, SA Muhsin, ... Clinical Journal of the American Society of Nephrology 16 (8), 1247-1255, 2021 | 51 | 2021 |
| Validation of plasma biomarker candidates for the prediction of eGFR decline in patients with type 2 diabetes A Heinzel, M Kammer, G Mayer, R Reindl-Schwaighofer, K Hu, P Perco, ... Diabetes care 41 (9), 1947-1954, 2018 | 51 | 2018 |
| Novel insights into non‐HLA alloimmunity in kidney transplantation R Reindl‐Schwaighofer, A Heinzel, GA Gualdoni, L Mesnard, FHJ Claas, ... Transplant International 33 (1), 5-17, 2020 | 50 | 2020 |
| Renoprotective and immunomodulatory effects of GDF15 following AKI invoked by ischemia-reperfusion injury J Liu, S Kumar, A Heinzel, M Gao, J Guo, GF Alvarado, ... Journal of the American Society of Nephrology 31 (4), 701-715, 2020 | 47 | 2020 |
| Torque teno virus load is associated with subclinical alloreactivity in kidney transplant recipients: a prospective observational trial K Doberer, F Haupenthal, M Nackenhorst, F Bauernfeind, F Dermuth, ... Transplantation 105 (9), 2112-2118, 2021 | 42 | 2021 |
| Randomized trial of etelcalcetide for cardiac hypertrophy in hemodialysis K Dörr, M Kammer, R Reindl-Schwaighofer, M Lorenz, T Prikoszovich, ... Circulation Research 128 (11), 1616-1625, 2021 | 42 | 2021 |
| MicroRNAs in kidney transplantation J Wilflingseder, R Reindl-Schwaighofer, J Sunzenauer, A Kainz, ... Nephrology Dialysis Transplantation 30 (6), 910-917, 2015 | 42 | 2015 |
| A phase I study assessing the safety, tolerability, immunogenicity, and low-density lipoprotein cholesterol-lowering activity of immunotherapeutics targeting PCSK9 M Zeitlinger, M Bauer, R Reindl-Schwaighofer, RM Stoekenbroek, ... European Journal of Clinical Pharmacology 77, 1473-1484, 2021 | 41 | 2021 |
